Unlike mammals, zebrafish efficiently regenerate functional nervous system tissue after major spinal cord injury. Whereas glial scarring presents a roadblock for mammalian spinal cord repair, glial cells in zebrafish form a bridge across severed spinal cord tissue and facilitate regeneration. We performed a genome-wide profiling screen for secreted factors that are up-regulated during zebrafish spinal cord regeneration. We found that connective tissue growth factor a (ctgfa) is induced in and around glial cells that participate in initial bridging events. Mutations in ctgfa disrupted spinal cord repair, and transgenic ctgfa overexpression or local delivery of human CTGF recombinant protein accelerated bridging and functional regeneration. Our study reveals that CTGF is necessary and sufficient to stimulate glial bridging and natural spinal cord regeneration.
T he spinal cord of adult zebrafish recovers spontaneously after injury (Fig. 1A and fig.  S1 , A and B). Efficient axon growth, adult neurogenesis, and absence of glial scarring distinguish this injury response from that in mammals (1, 2) . After initial inflammation, ependymal cells proliferate and glia form a bridge that is thought to provide a scaffold for axonal growth (3) . The severed cord reconnects, and new neuronal connections lead to functional recovery ( Fig. 1A) (4) . Here, we analyzed extracellular factors up-regulated in the regenerating zebrafish spinal cord.
To identify potential secreted, pro-regenerative signaling molecules, we screened zebrafish transcriptomes for genes induced after spinal cord injury ( Fig. 1B and table S1 ). Our screen identified seven genes encoding secreted extracellular proteins, including fibronectin 1 a (fn1a), previously implicated in axon growth promotion (5, 6) . Transcripts for fn1a, fn1b, connective tissue growth factor a (ctgfa), myostatin b (mstnb), and stanniocalcin 1 like (stc1l) increased in ependymal cells at 1 and 2 weeks post-injury (wpi) (Fig. 1C and fig. S1C ). Whereas fn1a was expressed around the entirety of the central canal at 2 wpi, mstnb and ctgfa were predominantly expressed in the dorsal and ventral ependyma, respectively (Fig. 1C) .
CTGF is a matricellular, multifunctional protein that can influence the activity of multiple major signaling pathways, affecting cell adhesion, migration, proliferation, and differentiation. CTGF expression increases after central nervous system (CNS) trauma in rodents, but its function after spinal cord injury has not been elucidated (7) (8) (9) . Because ctgfa is induced upon spinal cord injury in zebrafish, we hypothesized that it may have pro-regenerative roles. We analyzed ctgfa expression along the rostrocaudal spinal cord axis (Fig. 1D) . At 1 wpi, ctgfa transcription was induced in multiple cell types across the lesion site and in ependymal cells at the central canal near the lesion. At this time point, we detected strongest ctgfa expression in the ventral ependyma. By 2 wpi, ctgfa expression localized to ventral ependymal cells and marked the cellular bridge that had formed at the lesion site. Expression declined beyond 3 wpi ( fig. S2A ). Thus, ctgfa expression correlates with formation of the glial bridge.
To identify the cell populations that express ctgfa during spinal cord repair, we generated transgenic reporter zebrafish with a 5.5-kb genomic sequence upstream of the ctgfa translational start site fused to an enhanced green fluorescent protein (EGFP) reporter cassette. ctgfa:EGFP fluorescence resembled endogenous ctgfa mRNA expression in spinal cord tissue at 2 wpi ( fig. S2 , B and C). As early as 5 days post-injury (dpi), domains of ctgfa:EGFP and glial fibrillary acidic protein (GFAP), a marker of multiple glial cells in the CNS, overlapped within a subpopulation of glial cells at the injury site (Fig. 1E) . We interpret these to be bridging cells. Similarly, ctgfa: EGFP colocalized with the GFAP + bridge at 2 wpi (Fig. 1E) . Comparison of ctgfa:EGFP and GFAP expression on serial cross sections revealed that 97% of GFAP + bridging glia at the lesion core were also EGFP + at 1 wpi ( fig. S3 ). Further away from the lesion, ctgfa:EGFP was mainly present in ventral ependymal cells ( fig. S3 ). We also detected ctgfa:EGFP in skeletal muscle, bone cells, and reactive fibroblast-like cells around the lesion site. ctgfa-driven expression suggested delineation of "pioneer" bridging glia.
To determine whether ctgfa is required for spinal cord regeneration, we generated a ctgfa mutant allele (ctgfa bns50 ; referred to as ctgfa − ) that harbors a frameshift-causing 7-nucleotide deletion within the third exon of the ctgfa locus ( fig. S4 , A to C). ctgfa −/− animals are adult viable and appear to have unaffected motor function capacity (10) ( fig. S4D ). However, ctgfa −/− animals showed diminished swim capacity after spinal cord injury, with no significant functional recovery between 2 and 6 wpi ( Fig. 2A) . Heterozygous (ctgfa +/− ) animals showed partial recovery of swim capacity by 6 wpi ( Fig. 2A) . At 4 wpi, anterograde axon tracing indicated that axon regeneration across the lesion site was reduced bỹ 25% in ctgfa +/− and~60% in ctgfa −/− spinal cords proximal to the lesion, and by~40% in ctgfa +/− and~80% in ctgfa −/− cords distally (Fig. 2B) . Thus, ctgfa is required for spinal cord regeneration. Deficits in glial bridging might underlie the defects in spinal cord regeneration displayed by ctgfa mutants. Using GFAP and acetylated a-tubulin immunohistochemistry, we observed robust glial bridges in wild-type and ctgfa +/− animals at 4 wpi ( Fig. 2C and fig. S5A ). However, ctgfa −/− animals displayed~71% less bridging than did wild-type clutchmates ( Fig. 2C and fig. S5A ). At 2 wpi, glial cells within ctgfa −/− injury sites often failed to extend projections into the lesion ( fig. S5B ). 5-ethynyl-2′-deoxyuridine (EdU) incorporation assays showed that ctgfa −/− zebrafish displayed a~48% reduction in glial cell proliferation at 1 and 2 wpi (Fig. 2D and fig. S6 ). EdU + GFAP − cell numbers were comparable in wild-type, ctgfa
, and ctgfa −/− tissues at 1 wpi ( Fig. 2D ), which suggests that the effects of ctgfa mutations were preferential to glial cells. Thus, ctgfa is required for the changes in proliferation and morphology of glial cells during spinal cord regeneration.
To examine the effects of excess ctgfa on spinal cord regeneration, we generated and injured transgenic fish that express full-length ctgfa under control of a heat-inducible promoter (hsp70: ctgfa-FL) ( fig. S7 ). Recovery of swim capacity was improved in ctgfa-overexpressing animals given daily heat shocks and assessed at 2, 4, and 6 wpi (Fig. 3A) . Swim capacity was comparable between sham-injured hsp70:ctgfa-FL and wild-type clutchmates at 2 and 6 weeks after heat shock (Fig. 3A) , indicating contextual effects of ctgfa overexpression. Histology indicated increased bridging and axon regeneration in ctgfa-overexpressing fish relative to controls at 2 and 4 wpi, respectively (Fig. 3 , B and C, and fig. S8A ). Thus, whole-animal ctgfa overexpression promotes regeneration after spinal cord injury.
CTGF harbors four protein interaction domains and a protease domain that self-cleaves CTGF into profibrotic N-terminal and proliferative C-terminal peptides (11, 12) . To determine the active portion of zebrafish Ctgfa during spinal cord regeneration, we created transgenic fish with heat-inducible expression of either N-terminal or C-terminal ctgfa fragments (hsp70:ctgfa-NT and hsp70:ctgfa-CT) ( fig. S7A ). Only ctgfa-CT overexpression recapitulated the pro-regenerative effects of ctgfa-FL (Fig. 3 , D to F). By 6 wpi, swim capacity was markedly increased in ctgfa-CToverexpressing animals relative to ctgfa-NToverexpressing or wild-type clutchmates (Fig. 3D) . Anatomically, ctgfa-CT overexpression resulted in a factor of >3 increase in glial bridging at 2 wpi and a factor of >2 increase in axon growth at 4 wpi (Fig. 3, E and F, and fig. S8B ). These experiments indicate that the pro-regenerative activity of Ctgfa maps to its C-terminal domains.
To examine whether the effects of Ctgfa augmentation could be reproduced by localized delivery into the spinal cord lesion site, we injured wild-type animals and applied human recombinant CTGF (HR-CTGF-FL and HR-CTGF-CT) peptides adjacent to the lesion site at 5 and 10 dpi using a gelfoam sponge. We then assessed regeneration at 2 and 4 wpi, corresponding to 9 and 23 days after initial treatment. Human CTGF and zebrafish Ctgfa are 81% identical and 87% similar at the amino acid level within the four SCIENCE sciencemag.org (Fig. 3, G to I,  and fig. S8C ). Swim capacity was improved in HR-CTGF-FL-treated or HR-CTGF-CT-treated animals by 2 wpi (Fig. 3G) , near that of uninjured animals. As early as 1 wpi, we observed increased GFAP expression and a factor of >10 enhancement of glial bridging in HR-CTGF-CT-treated animals relative to vehicle-treated controls ( fig. S8D ). Bridging remained greater at 2 wpi by a factor of~3 (Fig. 3H) . At 4 wpi, axon regeneration was increased by a factor of~1.5 to 3 in HR-CTGF-FL-treated or HR-CTGF-CT-treated animals relative to vehicle controls (Fig. 3I) . Application of exogenous CTGF protein at the lesion site rescued functional and anatomical spinal cord regeneration in ctgfa mutants, indicating specificity of both the phenotype and treatment ( fig. S10) . Thus, human CTGF protein, ostensibly via its C-terminal domains, enhances spinal cord regeneration in zebrafish.
Glial cell responses are thought to dictate the outcomes of spinal cord injury across species. We , and 15 ctgfa −/− animals from two independent experiments were used. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant. Scale bars, 100 mm.
found that Ctgfa promotes zebrafish spinal cord regeneration, at least in part by facilitating the proliferation and bridging activity of pioneer glial cells that also express ctgfa. Other cell types also induce ctgfa in the injured zebrafish spinal cord and might contribute additional functions during regeneration. In mammals, reactive gliosis causes scarring and inhibits regeneration (13, 14), although evidence indicates that the lesion contains a heterogeneous pool of glial cells that release both axon growth-inhibiting and axon growth-permissive factors (6, (15) (16) (17) (18) (19) . We suggest , (E), and (H), dashed lines delineate glial GFAP staining and arrows point to sites of bridging. *P < 0.05, **P < 0.01, ***P < 0.001. Scale bars, 100 mm.
that identifying the mammalian glial subtype that can produce CTGF, or that is competent to respond to it, could reveal a pro-regenerative mammalian counterpart to the zebrafish bridging glia.
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We thank A. T he coleopteran insect western corn rootworm (WCR) (Diabrotica virgifera virgifera LeConte) and related species cause extensive damage to corn (Zea mays L.) in North America and Europe, resulting in crop yield losses and management costs (1) (2) (3) . Farmer adoption of corn plants that produce insecticidal proteins for controlling major corn pests, including WCRs, has increased productivity in areas with insect pressure (4). Commercial transgenic crops introduced to date for insect control have been developed with genes from Bacillus thuringiensis (Bt) (5, 6) . These genes encode insect-specific crystal proteins (Cry) or vegetative insecticidal proteins (Vip). Four of them-mCry3A, Cry3Bb1, eCry3.1Ab, and the binary protein complex Cry34Ab1/Cry35Ab1-have been commercialized for WCR control in the United States (5, 7). Emergence of WCR resistance to mCry3A, Cry3Bb1, and eCry3.1Ab proteins (8-10) under field conditions demonstrates the need for broader, more durable strategies to control insect infestations and limit the development of resistance. The genetic diversity of Bt has already been explored in a search for additional insecticidal proteins (5) . An alternative approach involves disabling WCR genes by RNA interference through the expression of double-stranded RNA (11) . We hypothesized that, like Bt, other soil bacteria that live with soil-dwelling coleopteran larvae may produce proteins that kill corn rootworms. Here we describe a potent and selective insecticidal protein from a Gram-negative bacterium, Pseudomonas chlororaphis, which we identified through screening soil-isolated microbial strains. This protein protects transgenic corn plants from WCR injury under field conditions.
We collected soil samples from the U.S. states of Iowa, Illinois, and Wisconsin, and isolated microbial strains under growth conditions to favor species other than Bt. Crude protein extracts from these isolates were screened for activity against WCRs in artificial diet bioassays. One isolate-identified as P. chlororaphis by 16S ribosomal DNA sequence analysis (12)-showed a potent inhibitory effect on WCRs. We used multistep chromatography to isolate the insecticidal protein and achieved high-purity (>80%) enrichment in the final step ( fig. S1 ). The major protein band with an apparent molecular weight of~10 kDa was digested with trypsin and subjected to identification by liquid chromatography-tandem mass spectrometry (LC-MS/MS). We used the LC-MS/ MS data of tryptic peptides to search against a protein database including protein sequences translated from the in-house genome sequence of this specific P. chlororaphis isolate. A highconfidence match to a hypothetical protein encoded by a gene from our specific P. chlororaphis isolate was obtained. This gene encodes a small protein of 86 amino acids, which we designated IPD072Aa (GenBank accession number KT795291). IPD072Aa was cloned and expressed in Escherichia coli to confirm that it was responsible for the insecticidal activity. Affinity-purified recombinant IPD072Aa was highly potent against WCR larvae and also active against northern corn rootworm (NCR) (Diabrotica barberi) larvae in diet bioassays (Fig. 1) .
To evaluate the activity spectrum, we tested purified recombinant IPD072Aa protein at concentrations up to 875 mg/ml in diet assays against several lepidopteran and hemipteran speciesincluding black cutworm (Agrotis ipsilon Hufnagel), corn earworm (Helicoverpa zea Boddie), European corn borer (Ostrinia nubilalis Hübner), fall armyworm (Spodoptera frugiperda J. E. Smith), soybean looper (Pseudoplusia includens Walker), and western tarnished plant bug (Lygus hesperus Knight)-and observed no mortality or inhibitory effect on any of those insect species. We also used an Agrobacterium-mediated transient gene expression system (13) to express IPD072Aa under control of a double-enhanced mirabilis mosaic virus viral promoter (14) in common bean (Phaseolus vulgaris). Sets of leaf disks transiently expressing
